Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: A double-blind, placebo-controlled study

Journal of Clinical Psychopharmacology

Volumn 9, Issue 6, 1989, Pages 403-406

  Kutcher, Stan ^a   Williamson, Peter ^c,d   MacKenzie, Susan ^a   Marton, Peter ^a,b   Ehrlich, Murray ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c London Psychiatric Hospital   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AKATHISIA; ARTICLE; FEMALE; HUMAN; MALE; MANIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLONAZEPAM; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMAN; MALE; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA;

EID: 0024808968     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Van Putten T. The many faces of akathisia. Compr Psychiatry 1975;16:43–7.
2. Braude WM, Barnes TRE, Gore SM. Clinical cnaracteristics of akathisia: a systematic investigation of acute psychiatric patient admissions. Br J Psychiatry 1983;143:139–50.
3. Van Putten T, May P, Marder S. Akathisia with haloperidol and thiothixene. Arch Gen Psychiatry 1984;41:1036–9.
4. Keepers G, Clappison V, Casey D. Initial anticholinergic prophylaxis for acute neuroleptic induced extrapyramidal syndromes. Arch Gen Psychiatry 1983;40:1113–7.
5. Van Putten T. Why do schizophrenic patients refuse to take tneir drugs? Arch Gen Psychiatry 1974;31:67–72.
6. Lipinski J, Zubenko G, Barreira P, Cohen B. Propranolol in the treatment of neuroleptic-induced akathisia. Lancet 1983;2:685–6.
7. Lipinski J, Zubenko G, Cohen B, Barreira P. Propranolol the treatment of neuroleptic-induced akathisia. Am J Psychiatry 1984;141:412–5.
8. Adler L, Angrist B, Peselow E, Corwin J, Manslansky R, Rotrosen J. A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia. Br.J Psychiatry 1986;149:42–5.
9. Zubenko G, Lipinski J, Cohen B, Barreira P. Comparison of metoprolol and propranolol in the treatment of akathisia. Psychiatry Res 1984;11:143–8.
10. Zubenko G, Cohen B, Lipinski J, Jonas J. Use of clonidine in treating neuroleptic-induced akathisia. Am J Psychiatry 1984;144:235–6.
11. Adler L, Angrist B, Peselow E, Reitano J, Rotrosen J. Clonidine in neuroleptic-induced akathisia. Am J Psychiatry 1987;144:235–6
12. Read D, Feest T, Nassimm M. Clonazepam effective treatment for restless leg syndrome in uraemia. Br Med J 1981;283:885–6.
13. Montagna P. Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lagaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984;69:428–30
14. Kutcher S, MacKenzie S, Galarraga W, Szalai J. Clonazepam treatment of adolescents with neuroleptic-induced akathisia. Am J Psychiatry 1987;144:829–4.
15. Chouinard G, Ross-Chouinard A, Annable L, Jones B. Extrapyramidal rating scale. Can J Neurol Sci 1980;1:233–40.
16. Arendt R. Greenblatt D. Liebisch DC. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology 1987;93:72–6.
17. Goodman Gilman A, Goodman L, Rall T, eds. Goodman and Gilman’s, the pharmacological basis of therapeutics. Macmillan Co, 1985.
18. Chadwick D, Hallett M, Harris R. Clinical, biochemical and physiological features distinguishing myoclonus responsive to 5-hy-droxytryptophan. tryptophan with a monoamine oxidase inhibitor, and clonazepam. Brain 1977;100:455–87.
19. Chouinard G. Clonazepam in acute and maintenance treatment of bipolar affective disorder. J Clin Psychiatry 1987;48:29–87.
20. Randall P. Kappell B. Pharmacological activity of some benzodiazepines and their metabolites. In: Garattini S. Mussini E. Randall P, eds. The benzodiazepines. New York: Raven Press, 1973;27–51.
21. Greenblatt D, Miller L, Shader RI. Clonazepam pharmacokinetics, brain uptake, and receptor interactions. J Clin Psychiatiy 1987;48:4–9.
22. Miller L, Freidman H, Greenblatt D. Measurement of clonazepam by electron-capture gas liquid chromatography with application to single dose pharmacokineties. J Anal Toxicol 1987;11:55–7.